Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapy

Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapy

Background: To evaluate the efficacy and optimal timing of local treatment in patients with borderline resectable (BR) or locally advanced pancreatic cancer (LAPC) treated with upfront FOLFIRINOX. Method: Between 2015 and 2020, 258 patients with pancreatic ductal adenocarcinoma (PDAC) were analysed....

Full description

Bibliographic Details
Main Authors: Kangpyo Kim, Hee Chul Park, Jeong Il Yu, Joon Oh Park, Jung Yong Hong, Kyu Taek Lee, Kwang Hyuck Lee, Jong Kyun Lee, Joo Kyung Park, Jin Seok Heo, Sang Hyun Shin, Ji Hye Min, Kyunga Kim, In Woong Han
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Pancreatic ductal adenocarcinoma
Multimodal treatments
Timing of local treatments
Neoadjuvant treatment
FOLFIRINOX
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630824000090

Internet

http://www.sciencedirect.com/science/article/pii/S2405630824000090

Similar Items